Stockreport

Portnoy Law Firm Announces Class Action on Behalf of Jasper Therapeutics, Inc. Investors

Jasper Therapeutics, Inc. - Class A  (JSPR) 
PDF LOS ANGELES, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Jasper Therapeutics, Inc., (“Jasper” or the "Company") (NASDAQ: JSPR) investors of a class [Read more]